Results from the photon cohort of NRG-BN001, a signal seeking Phase II randomized trial, has delivered hope to patients battling glioblastoma, one of the most aggressive brain tumors, suggesting that…
Ten percent higher 5-year overall survival rates in patients receiving precise proton therapy vs. traditional radiation therapy Patients had significantly fewer side effects and improved quality of life, including less…
Last fall, experts from across the country gathered at the NAPT Research Forum in Washington, D.C. to discuss one of the most pressing issues in cancer care today: how to…
2025 NAPT Annual Member Survey Highlights Increases in Patients and Conditions Treated; Continued Barriers to Access, Including Prior Authorization Delays, and Insurance Denials JACKSONVILLE, FL, September 29, 2025 -…
Article by: Texas Center for Proton Therapy A study published in the Journal of Clinical Oncology reports that incidences of cardiac dysfunction amongst breast cancer survivors increased eightfold within the…
The National Association for Proton Therapy (NAPT) hosted its first-ever Research Forum in Washington, DC, gathering top researchers, clinicians, and industry leaders from across the nation to explore cutting-edge developments…
A recent study published in JAMA Network Open highlights significant disparities in travel-time access to proton beam therapy (PBT) for cancer treatment across the contiguous United States. Proton beam therapy,…
